Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemostasis in liver disease.

D A Kelly1, J A Summerfield

  • 1Department of Medicine, Royal Free Hospital, London, England.

Seminars in Liver Disease
|August 1, 1987
PubMed
Summary
This summary is machine-generated.

Liver disease causes complex blood clotting issues due to protein synthesis and clearance problems. Understanding these hemostatic defects is key for developing better treatments for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The necessity of education and hepatitis B vaccination for young people: A study of high risk behaviour for blood borne viruses in the United Kingdom.

Journal of child health care : for professionals working with children in the hospital and community·2019
Same author

A 10-year longitudinal follow-up study of a U.K. paediatric transplant population to assess for skin cancer.

The British journal of dermatology·2018
Same author

"Are these adult doctors gonna know me?" Experiences of transition for young people with a liver transplant.

Pediatric transplantation·2016
Same author

Parents in transition: Experiences of parents of young people with a liver transplant transferring to adult services.

Pediatric transplantation·2016
Same author

Selenium homocholic acid taurocholate scanning, selenium-75-labeled bile acid, a novel method for testing the function of the terminal ileum in small bowel transplant recipients: a pilot study.

Transplantation proceedings·2014
Same author

Treatment of chronic viral hepatitis C in children and adolescents: UK experience.

Archives of disease in childhood·2014
Same journal

Endothelial Cell Therapy for the Acute and Chronic Liver Disease.

Seminars in liver disease·2026
Same journal

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Seminars in liver disease·2026
Same journal

Expert Practical Recommendations for Hepatocellular Carcinoma.

Seminars in liver disease·2026
Same journal

Optimizing Liver Cancer Care Through BCLC Principles.

Seminars in liver disease·2026
Same journal

Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.

Seminars in liver disease·2026
Same journal

Practical Guide to Best Practices in Alcohol-Associated Liver Disease.

Seminars in liver disease·2026
See all related articles

Area of Science:

  • Hepatology
  • Hematology
  • Coagulation Science

Background:

  • Liver disease presents diverse coagulation abnormalities.
  • Parenchymal liver disease is linked to reduced protein and inhibitor synthesis.
  • Cirrhosis can lead to dysfibrinogenemia and hypersplenism, while cholestasis may elevate certain coagulation factors.

Purpose of the Study:

  • To explore the complex hemostatic defects in patients with liver disease.
  • To elucidate the multifactorial nature of coagulation problems in liver disease.
  • To highlight the role of molecular genetics and immunology in understanding these defects.

Main Methods:

  • Review of existing literature on coagulation in liver disease.
  • Analysis of protein synthesis and clearance mechanisms.

Related Experiment Videos

  • Examination of qualitative and quantitative protein abnormalities.

    • Main Results:

    • Patients with parenchymal liver disease show reduced synthesis of coagulation proteins and inhibitors.
    • Cirrhosis is associated with dysfibrinogenemia and hypersplenism.
    • Cholestasis without cirrhosis may result in elevated fibrinogen, Factor V, and Factor VIII levels due to impaired protein clearance.

    Conclusions:

    • Hemostatic defects in liver disease are complex, multifactorial, and often unpredictable.
    • Both qualitative and quantitative abnormalities of coagulation proteins contribute to hemostasis issues.
    • Advances in molecular genetics and immunology are crucial for future understanding and therapy development.